Clinical Trials
11 trialsNCT02450396 2026-03-27
EGR2
Assistance Publique - Hôpitaux de Paris
Withdrawn
NCT03284879 2025-09-08
Post-Marketing Surveillance Study of OTEZLA
Amgen
Completed
NCT02638701 2025-07-08
Infliximab Therapy for Dolichoectactic Vertebrobasilar Aneurysms
University of California, San Francisco
Phase 1/2 Recruiting
NCT04870333 2025-06-20
PROTECT-V
Cambridge University Hospitals NHS Foundation Trust
Phase 2/3 Completed
NCT05635266 2024-05-07
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives
Sanguine Biosciences
Recruiting
NCT06065852 2023-10-04
RaDaR
UK Kidney Association
Recruiting
NCT03941184 2020-11-23
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity
Mayo Clinic
Completed
NCT02084147 2019-10-29
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Case Comprehensive Cancer Center
Phase NA Completed
NCT00001156 2017-07-02
Assessment of Patients With Multiple Sclerosis (MS)
National Institutes of Health Clinical Center (CC)
Completed
NCT00001901 2008-03-04
Etanercept to Treat Wegener's Granulomatosis
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00005007 2007-12-28
Etanercept for Wegener's Granulomatosis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Phase 2/3 Completed